Leo Price,
CEO,
Ocello B.V
Leo Price was trained as a cell biologist and has held positions in London, San Diego, Amsterdam and Utrecht in cancer research. From 2005, he ran a research group at Leiden University, where he developed 3D tissue culture based screening technology. This technology was spun off as OcellO, a contract research company that develops physiologically relevant models of disease and uses these to offer compound screening and profiling services for the drug discovery industry.
|
|
|
Add to Calendar ▼2017-04-26 14:30:002017-04-26 15:30:00Europe/LondonScreening and Profiling of Cancer Therapeutics in Primary and Stem Cell-derived Human 3D TissuesHigh Content and Phenotypic Screening 2017 in Holiday Inn, Cambridge, UKHoliday Inn, Cambridge, UKSELECTBIOenquiries@selectbiosciences.com
